# OnCo record nct05393713 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05393713/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05393713", "NCT05393713" ;
  schema:name "Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study"@en ;
  schema:description "A phase 1 trial of IMC-001 run by Mayo Clinic, terminated."@en ;
  schema:url <https://onco.cc/trials/nct05393713/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05393713> ;
  onco:status "historic" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/advanced-melanoma/> ;
  onco:drugs <https://onco.cc/drugs/imc-001/> ;
  onco:companies <https://onco.cc/companies/immuneoncia-therapeutics/> .